Samar Alabassy is a Webster, New York based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. Her current practice location is 98 North Ave, Webster. Patients can book an appointment with her at 585-210-0150.
Samar Alabassy is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Samar Alabassy speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Samar Alabassy
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Female
Credentials:
ATR-P
Accepts Medicare Assignment:
No
Practice Address:
98 North Ave, Webster, New York, 14580-3193
Phone:
585-210-0150
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1841919941
NPI Enumeration Date:
23 Aug, 2022
NPI Last Update On:
23 Aug, 2022
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
98 North Ave, Webster, New York
Zip:
14580-3193
Phone Number:
585-210-0150
Patients can reach Samar Alabassy at 98 North Ave, Webster, New York or can call to book an appointment on 585-210-0150. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.